-----

Welcome to the May 2013 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, an update on Big Pharma’s investment in biologic-based manufacturing capacity and an analysis of biotech financing trends in North America and Europe. And analysis of the pharmaceutical industry’s participation in global vaccine initiatives and other news from the pharmaceutical/biopharmaceutical companies and their suppliers relating to global health initiatives and sustainability.

Global Feature
Big Pharma's Investment in Biologics
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Bristol-Myers Squibb, Novartis, GlaxoSmithKline, Sanofi, and Roche are among the companies expanding biologic-based manufacturing capacity.
>> Read More

Biologics
The New Normal in Biotech Financing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Financing to biotech companies in North America and Europe declined in 2012 as debt funding decreased and the IPO market remained weak.
>> Read More

Outsourcing
Strategic Partnering for Manufacturing
Jim Miller, president of PharmSource Information Services
Eisai and Biogen Idec pursue an innovative approach to capacity management.
>> Read More

Pharma Industry’s Global Health and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
>> Read More

Pharma Industry’s Global Health and Sustainability Forum
Pharma Industry Participates in Vaccine Initiatives
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
The Global Vaccine Action plan maps out a strategy to increase access and R&D for vaccines.
>> Read More

Industry Events

For the full listing of calendar events, see the Calendar of Events page

Free Pharmaceutical Technology Webcast
New Strategies for Evaluating Biopharmaceutical Stability
May 9, 2:00 to 3:00 PM EST
The size and complexity of most biopharmaceuticals provide fertile ground for intramolecular changes and multiple routes of degradation and related effects. Learn from leading industry experts in this 60-minute webcast of the common pitfalls of biopharmaceutical stability testing, regulatory agencies’ expectations for supporting data, and the analytical techniques that can streamline the development process.
Registration information